Acadia Pharmaceuticals will replace Independent Bank Group in the S&P SmallCap 600


  • Acadia Pharmaceuticals (NASDAQ:ACAD) will replace Independent Banking Group (NASDAQ:IBTX) in the S&P SmallCap 600 effective before the open of trading on Friday, January 3, 2025.
  • S&P MidCap 400 constituent SouthState (SSB) is acquired by Independent Bank Group (IBTX) in a deal that is expected to close soon pending final terms.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *